Racial/Ethnic Minorities Underrepresented in Alzheimer Neuroimaging Research
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 28, 2023 -- Racial and ethnic minority groups are underrepresented in Alzheimer disease neuroimaging literature, according to a study published online July 25 in Communications Medicine.
Aaron C. Lim, Ph.D., from the Keck School of Medicine of USC in Alhambra, California, and colleagues identified median race/ethnicity composition of Alzheimer disease neuroimaging U.S.-based research samples in published studies. Studies that directly reported race/ethnicity data (direct studies) and those that did not report race/ethnicity, but used data from a cohort study/database that did report this information (indirect studies), were analyzed.
The researchers found that in the 719 direct studies, the median representation was 88.9 percent White or 87.4 percent non-Hispanic White, 7.3 percent Black/African American, and 3.4 percent Hispanic/Latino ethnicity; no Asian American, Native Hawaiian/Pacific Islander, and American Indian/Alaska Native, multiracial, or "other race" participants were included. The 44 cohort studies/databases from which 1,745 indirect studies were derived were more diverse and included median representation of 84.2 percent White, 83.7 percent non-Hispanic White, 11.6 percent Black/African Americans, 4.7 percent Hispanic/Latino, and 1.75 percent Asian American participants. Most of the indirect studies (94 percent) were derived from 10 cohort studies/databases. Sample diversity improved recently comparing two time periods using a median split for publication year (1994 to 2017 and 2018 to 2022), especially for Black/African American participants (3.39 and 8.29 percent in 1994-2017 and 2018-2022, respectively).
"This is a pretty big deal, especially as we look toward the future, where an increasing proportion of the U.S. will be ethnic minority groups," Lim said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181
MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...
Lower Cognitive Function in Adolescence Linked to Stroke Risk
FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.